(KODK) Eastman Kodak - Overview
Stock: Print Plates, Digital Presses, Inks, Films, Licensing
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 60.7% |
| Relative Tail Risk | -12.7% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.22 |
| Alpha | -23.32 |
| Character TTM | |
|---|---|
| Beta | 1.710 |
| Beta Downside | 1.335 |
| Drawdowns 3y | |
|---|---|
| Max DD | 45.38% |
| CAGR/Max DD | 0.65 |
Description: KODK Eastman Kodak December 27, 2025
Eastman Kodak Co. (KODK) operates worldwide through three primary segments: Print, Advanced Materials & Chemicals, and Brand licensing. The Print segment delivers digital offset plates, computer-to-plate imaging, digital printing hardware, inks (e.g., KODAK OPTIMAX) and workflow software (PRINERGY) to commercial print, direct-mail, publishing, newspaper, décor and packaging customers.
The Advanced Materials & Chemicals segment encompasses industrial film, specialty chemicals, motion-picture supplies, functional printing materials, and the Kodak Research Laboratories, which drive IP creation and licensing. The Brand segment monetizes the Kodak name through licensing agreements, while the Eastman Business Park provides a technology hub and industrial space for third-party tenants.
Recent financial snapshots (FY 2023) show total revenue of roughly $1.2 billion, with the Print segment contributing about 45 % of sales, Advanced Materials ≈ 30 %, and Brand licensing ≈ 15 %. The company’s free cash flow remains modest (~$30 million) and it carries roughly $300 million of long-term debt, underscoring the importance of cash-generating growth in high-margin packaging and functional-printing markets.
Key sector drivers include a 5-6 % CAGR in flexible-packaging printing demand, heightened focus on sustainable inks and coatings, and a broader shift toward digital workflow automation that benefits software-as-a-service models like PRINERGY.
For a deeper quantitative dive, the ValueRay platform provides up-to-date metrics and scenario analysis for KODK.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: 6.00m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.02 > 0.02 and ΔFCF/TA -2.07 > 1.0 |
| NWC/Revenue: -15.02% < 20% (prev 35.74%; Δ -50.77% < -1%) |
| CFO/TA -0.00 > 3% & CFO -5.00m > Net Income 6.00m |
| Net Debt (381.0m) to EBITDA (100.0m): 3.81 < 3 |
| Current Ratio: 0.79 > 1.5 & < 3 |
| Outstanding Shares: last quarter (89.8m) vs 12m ago -2.81% < -2% |
| Gross Margin: 20.67% > 18% (prev 0.19%; Δ 2048 % > 0.5%) |
| Asset Turnover: 46.83% > 50% (prev 44.05%; Δ 2.78% > 0%) |
| Interest Coverage Ratio: 1.16 > 6 (EBITDA TTM 100.0m / Interest Expense TTM 62.0m) |
Altman Z'' -1.36
| A: -0.08 (Total Current Assets 592.0m - Total Current Liabilities 749.0m) / Total Assets 2.08b |
| B: -0.20 (Retained Earnings -413.0m / Total Assets 2.08b) |
| C: 0.03 (EBIT TTM 72.0m / Avg Total Assets 2.23b) |
| D: -0.41 (Book Value of Equity -495.0m / Total Liabilities 1.21b) |
| Altman-Z'' Score: -1.36 = CCC |
Beneish M -3.10
| DSRI: 1.03 (Receivables 146.0m/143.0m, Revenue 1.04b/1.05b) |
| GMI: 0.93 (GM 20.67% / 19.20%) |
| AQI: 0.94 (AQ_t 0.60 / AQ_t-1 0.64) |
| SGI: 0.99 (Revenue 1.04b / 1.05b) |
| TATA: 0.01 (NI 6.00m - CFO -5.00m) / TA 2.08b) |
| Beneish M-Score: -3.10 (Cap -4..+1) = AA |
What is the price of KODK shares?
Over the past week, the price has changed by +5.19%, over one month by -8.33%, over three months by +31.62% and over the past year by -4.70%.
Is KODK a buy, sell or hold?
What are the forecasts/targets for the KODK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 1 | -87% |
| Analysts Target Price | 1 | -87% |
| ValueRay Target Price | 7.7 | -0.4% |
KODK Fundamental Data Overview February 03, 2026
P/B = 0.9551
Revenue TTM = 1.04b USD
EBIT TTM = 72.0m USD
EBITDA TTM = 100.0m USD
Long Term Debt = 10.0m USD (from longTermDebt, last quarter)
Short Term Debt = 509.0m USD (from shortTermDebt, last quarter)
Debt = 549.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 381.0m USD (from netDebt column, last quarter)
Enterprise Value = 1.15b USD (769.3m + Debt 549.0m - CCE 168.0m)
Interest Coverage Ratio = 1.16 (Ebit TTM 72.0m / Interest Expense TTM 62.0m)
EV/FCF = -23.01x (Enterprise Value 1.15b / FCF TTM -50.0m)
FCF Yield = -4.35% (FCF TTM -50.0m / Enterprise Value 1.15b)
FCF Margin = -4.78% (FCF TTM -50.0m / Revenue TTM 1.04b)
Net Margin = 0.57% (Net Income TTM 6.00m / Revenue TTM 1.04b)
Gross Margin = 20.67% ((Revenue TTM 1.04b - Cost of Revenue TTM 829.0m) / Revenue TTM)
Gross Margin QoQ = 25.28% (prev 19.39%)
Tobins Q-Ratio = 0.55 (Enterprise Value 1.15b / Total Assets 2.08b)
Interest Expense / Debt = 3.28% (Interest Expense 18.0m / Debt 549.0m)
Taxrate = 18.75% (3.00m / 16.0m)
NOPAT = 58.5m (EBIT 72.0m * (1 - 18.75%))
Current Ratio = 0.79 (Total Current Assets 592.0m / Total Current Liabilities 749.0m)
Debt / Equity = 0.64 (Debt 549.0m / totalStockholderEquity, last quarter 861.0m)
Debt / EBITDA = 3.81 (Net Debt 381.0m / EBITDA 100.0m)
Debt / FCF = -7.62 (negative FCF - burning cash) (Net Debt 381.0m / FCF TTM -50.0m)
Total Stockholder Equity = 813.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.27% (Net Income 6.00m / Total Assets 2.08b)
RoE = 0.74% (Net Income TTM 6.00m / Total Stockholder Equity 813.2m)
RoCE = 8.75% (EBIT 72.0m / Capital Employed (Equity 813.2m + L.T.Debt 10.0m))
RoIC = 5.28% (NOPAT 58.5m / Invested Capital 1.11b)
WACC = 8.24% (E(769.3m)/V(1.32b) * Re(12.22%) + D(549.0m)/V(1.32b) * Rd(3.28%) * (1-Tc(0.19)))
Discount Rate = 12.22% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 6.21%
Fair Price DCF = unknown (Cash Flow -50.0m)
EPS Correlation: -14.27 | EPS CAGR: 3.09% | SUE: N/A | # QB: 0
Revenue Correlation: -80.57 | Revenue CAGR: -3.46% | SUE: N/A | # QB: 0